{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:34:42Z","timestamp":1787668482568,"version":"build-2736575974"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T00:00:00Z","timestamp":1720742400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T00:00:00Z","timestamp":1720742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s11102-024-01428-6","type":"journal-article","created":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T07:02:07Z","timestamp":1720767727000},"page":"644-653","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Outcome of non-functioning ACTH pituitary tumors: silent does not mean indolent"],"prefix":"10.1007","volume":"27","author":[{"given":"Nicolas","family":"Sahakian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Goetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Appay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Graillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Raingeard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cilia","family":"Piazzola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Regis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Castinetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Brue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Dufour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Cuny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,12]]},"reference":[{"key":"1428_CR1","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ecl.2020.04.002","volume":"49","author":"AF Daly","year":"2020","unstructured":"Daly AF, Beckers A (2020) The epidemiology of Pituitary Adenomas. Endocrinol Metab Clin North Am 49:347\u2013355. https:\/\/doi.org\/10.1016\/j.ecl.2020.04.002","journal-title":"Endocrinol Metab Clin North Am"},{"key":"1428_CR2","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1056\/nejmra1810772","volume":"382","author":"S Melmed","year":"2020","unstructured":"Melmed S (2020) Pituitary-Tumor Endocrinopathies. N Engl J Med 382:937\u2013950. https:\/\/doi.org\/10.1056\/nejmra1810772","journal-title":"N Engl J Med"},{"key":"1428_CR3","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s11060-013-1354-5","volume":"117","author":"ED Aflorei","year":"2014","unstructured":"Aflorei ED, Korbonits M (2014) Epidemiology and etiopathogenesis of pituitary adenomas. J Neurooncol 117:379\u2013394. https:\/\/doi.org\/10.1007\/s11060-013-1354-5","journal-title":"J Neurooncol"},{"key":"1428_CR4","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/J.1365-2265.2009.03667.X","volume":"72","author":"A Fernandez","year":"2010","unstructured":"Fernandez A, Karavitaki N, Wass JAH (2010) Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin Endocrinol (Oxf) 72:377\u2013382. https:\/\/doi.org\/10.1111\/J.1365-2265.2009.03667.X","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1428_CR5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/S12022-022-09703-7","volume":"33","author":"SL Asa","year":"2022","unstructured":"Asa SL, Mete O, Perry A, Osamura RY (2022) Overview of the 2022 WHO classification of Pituitary tumors. Endocr Pathol 33:6\u201326. https:\/\/doi.org\/10.1007\/S12022-022-09703-7","journal-title":"Endocr Pathol"},{"key":"1428_CR6","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1007\/S12020-017-1447-6","volume":"58","author":"F Langlois","year":"2017","unstructured":"Langlois F, Lim DST, Varlamov E et al (2017) Clinical profile of silent growth hormone pituitary adenomas; higher recurrence rate compared to silent gonadotroph pituitary tumors, a large single center experience. Endocrine 58:528\u2013534. https:\/\/doi.org\/10.1007\/S12020-017-1447-6","journal-title":"Endocrine"},{"key":"1428_CR7","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1097\/00000478-200310000-00005","volume":"27","author":"DH George","year":"2003","unstructured":"George DH, Scheithauer BW, Kovacs K et al (2003) Crooke\u2019s cell adenoma of the pituitary: an aggressive variant of corticotroph adenoma. Am J Surg Pathol 27:1330\u20131336. https:\/\/doi.org\/10.1097\/00000478-200310000-00005","journal-title":"Am J Surg Pathol"},{"key":"1428_CR8","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/S10014-022-00441-6","volume":"39","author":"S Portovedo","year":"2022","unstructured":"Portovedo S, Neto LV, Soares P et al (2022) Aggressive nonfunctioning pituitary neuroendocrine tumors. Brain Tumor Pathol 39:183\u2013199. https:\/\/doi.org\/10.1007\/S10014-022-00441-6","journal-title":"Brain Tumor Pathol"},{"key":"1428_CR9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00401-013-1084-y","volume":"126","author":"J Trouillas","year":"2013","unstructured":"Trouillas J, Roy P, Sturm N et al (2013) A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case\u2013control study of 410 patients with 8 years post-operative follow-up. Acta Neuropathol 126:123\u2013135. https:\/\/doi.org\/10.1007\/s00401-013-1084-y","journal-title":"Acta Neuropathol"},{"key":"1428_CR10","doi-asserted-by":"publisher","first-page":"3368","DOI":"10.1210\/jc.2017-00773","volume":"102","author":"G Raverot","year":"2017","unstructured":"Raverot G, Dantony E, Beauvy J et al (2017) Risk of recurrence in pituitary neuroendocrine tumors: a prospective study using a five-tiered classification. J Clin Endocrinol Metab 102:3368\u20133374. https:\/\/doi.org\/10.1210\/jc.2017-00773","journal-title":"J Clin Endocrinol Metab"},{"key":"1428_CR11","doi-asserted-by":"publisher","unstructured":"Lelotte J, Mourin A, Fomekong E et al (2018) Both invasiveness and proliferation criteria predict recurrence of non-functioning pituitary macroadenomas after surgery: a retrospective analysis of a monocentric cohort of 120 patients. 178:237\u2013246. https:\/\/doi.org\/10.1530\/EJE-17-0965","DOI":"10.1530\/EJE-17-0965"},{"key":"1428_CR12","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1530\/EJE-18-0749","volume":"180","author":"S Asioli","year":"2019","unstructured":"Asioli S, Righi A, Iommi M et al (2019) Validation of a clinicopathological score for the prediction of post-surgical evolution of pituitary adenoma: retrospective analysis on 566 patients from a tertiary care centre. Eur J Endocrinol 180:127\u2013134. https:\/\/doi.org\/10.1530\/EJE-18-0749","journal-title":"Eur J Endocrinol"},{"key":"1428_CR13","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1530\/EJE-22-0812","volume":"187","author":"N Sahakian","year":"2022","unstructured":"Sahakian N, Appay R, Resseguier N et al (2022) Real-life clinical impact of a five-tiered classification of pituitary tumors. Eur J Endocrinol 187:893\u2013904. https:\/\/doi.org\/10.1530\/EJE-22-0812","journal-title":"Eur J Endocrinol"},{"key":"1428_CR14","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1093\/EJENDO\/LVAD079","volume":"189","author":"NF Lenders","year":"2023","unstructured":"Lenders NF, Earls PE, Wilkinson AC et al (2023) Predictors of pituitary tumour behaviour: an analysis from long-term follow-up in 2 tertiary centres. Eur J Endocrinol 189:106\u2013114. https:\/\/doi.org\/10.1093\/EJENDO\/LVAD079","journal-title":"Eur J Endocrinol"},{"key":"1428_CR15","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/S11102-023-01319-2","volume":"26","author":"C Peixe","year":"2023","unstructured":"Peixe C, Alexandre MI, Gomes AR et al (2023) Usefulness of a clinicopathological classification in predicting treatment-related outcomes and multimodal therapeutic approaches in pituitary adenoma patients: retrospective analysis on a Portuguese cohort of 129 patients from a tertiary pituitary center. Pituitary 26:352\u2013363. https:\/\/doi.org\/10.1007\/S11102-023-01319-2","journal-title":"Pituitary"},{"key":"1428_CR16","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/cen.14197","volume":"93","author":"F Guaraldi","year":"2020","unstructured":"Guaraldi F, Zoli M, Righi A et al (2020) A practical algorithm to predict postsurgical recurrence and progression of pituitary neuroendocrine tumours (PitNET)s. Clin Endocrinol (Oxf) 93:36\u201343. https:\/\/doi.org\/10.1111\/cen.14197","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1428_CR17","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1159\/000442327","volume":"45","author":"J-FF Bonneville","year":"2016","unstructured":"Bonneville J-FF (2016) Magnetic resonance imaging of Pituitary tumors. Front Horm Res 45:97\u2013120. https:\/\/doi.org\/10.1159\/000442327","journal-title":"Front Horm Res"},{"key":"1428_CR18","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1227\/00006123-199310000-00008","volume":"33","author":"E Knosp","year":"1993","unstructured":"Knosp E, Steiner E, Kitz K, Matula C (1993) Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33:610\u2013618. https:\/\/doi.org\/10.1227\/00006123-199310000-00008","journal-title":"Neurosurgery"},{"key":"1428_CR19","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","volume":"9","author":"M Fleseriu","year":"2021","unstructured":"Fleseriu M, Auchus R, Bancos I et al (2021) Consensus on diagnosis and management of Cushing\u2019s disease: a guideline update. Lancet Diabetes Endocrinol 9:847\u2013875. https:\/\/doi.org\/10.1016\/S2213-8587(21)00235-7","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1428_CR20","doi-asserted-by":"publisher","unstructured":"Zhang K, Shou X, Chen H et al (2021) Clinical parameters of Silent Corticotroph Adenomas with positive and negative adrenocorticotropic hormone immunostaining: a large retrospective single-center study of 105 cases. Front Endocrinol (Lausanne) 11. https:\/\/doi.org\/10.3389\/FENDO.2020.608691","DOI":"10.3389\/FENDO.2020.608691"},{"key":"1428_CR21","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1227\/NEU.0B013E318257C1F0","volume":"71","author":"AG Ioachimescu","year":"2012","unstructured":"Ioachimescu AG, Eiland L, Chhabra VS et al (2012) Silent corticotroph adenomas: Emory University cohort and comparison with ACTH-negative nonfunctioning pituitary adenomas. Neurosurgery 71:296\u2013303. https:\/\/doi.org\/10.1227\/NEU.0B013E318257C1F0","journal-title":"Neurosurgery"},{"key":"1428_CR22","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1227\/01.NEU.0000429858.96652.1E","volume":"73","author":"A Jahangiri","year":"2013","unstructured":"Jahangiri A, Wagner JR, Pekmezci M et al (2013) A comprehensive long-term retrospective analysis of silent corticotrophic adenomas vs hormone-negative adenomas. Neurosurgery 73:8\u201317. https:\/\/doi.org\/10.1227\/01.NEU.0000429858.96652.1E","journal-title":"Neurosurgery"},{"key":"1428_CR23","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1530\/EC-20-0035","volume":"9","author":"S Castellnou","year":"2020","unstructured":"Castellnou S, Vasiljevic A, Lapras V et al (2020) SST5 expression and USP8 mutation in functioning and silent corticotroph pituitary tumors. Endocr Connect 9:243\u2013253. https:\/\/doi.org\/10.1530\/EC-20-0035","journal-title":"Endocr Connect"},{"key":"1428_CR24","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1530\/EJE.1.02326","volume":"156","author":"DK L\u00fcdecke","year":"2007","unstructured":"L\u00fcdecke DK, Buchfelder M, Fahlbusch R et al (2007) Pathohistological classification of pituitary tumors: 10 years of experience with the German pituitary Tumor Registry. Eur J Endocrinol 156:203\u2013216. https:\/\/doi.org\/10.1530\/EJE.1.02326","journal-title":"Eur J Endocrinol"},{"key":"1428_CR25","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.3171\/2020.10.JNS203236","volume":"135","author":"BA Strickland","year":"2021","unstructured":"Strickland BA, Shahrestani S, Briggs RG et al (2021) Silent corticotroph pituitary adenomas: clinical characteristics, long-term outcomes, and management of disease recurrence. J Neurosurg 135:1706\u20131713. https:\/\/doi.org\/10.3171\/2020.10.JNS203236","journal-title":"J Neurosurg"},{"key":"1428_CR26","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/S11102-017-0844-4","volume":"21","author":"F Langlois","year":"2018","unstructured":"Langlois F, Lim DST, Yedinak CG et al (2018) Predictors of silent corticotroph adenoma recurrence; a large retrospective single center study and systematic literature review. Pituitary 21:32\u201340. https:\/\/doi.org\/10.1007\/S11102-017-0844-4","journal-title":"Pituitary"},{"key":"1428_CR27","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/S12020-023-03449-W","volume":"82","author":"HG Vuong","year":"2023","unstructured":"Vuong HG, Dunn IF (2023) The clinicopathological features and prognosis of silent corticotroph tumors: an updated systematic review and meta-analysis. Endocrine 82:527\u2013535. https:\/\/doi.org\/10.1007\/S12020-023-03449-W","journal-title":"Endocrine"},{"key":"1428_CR28","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1007\/S00701-021-04911-2","volume":"163","author":"A Goyal-Honavar","year":"2021","unstructured":"Goyal-Honavar A, Sarkar S, Asha HS et al (2021) A clinicoradiological analysis of silent corticotroph adenomas after the introduction of pituitary-specific transcription factors. Acta Neurochir (Wien) 163:3143\u20133154. https:\/\/doi.org\/10.1007\/S00701-021-04911-2","journal-title":"Acta Neurochir (Wien)"},{"key":"1428_CR29","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1007\/S11102-021-01133-8","volume":"24","author":"S Jiang","year":"2021","unstructured":"Jiang S, Zhu J, Feng M et al (2021) Clinical profiles of silent corticotroph adenomas compared with silent gonadotroph adenomas after adopting the 2017 WHO pituitary classification system. Pituitary 24:564\u2013573. https:\/\/doi.org\/10.1007\/S11102-021-01133-8","journal-title":"Pituitary"},{"key":"1428_CR30","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/CEN.12443","volume":"81","author":"L Cazabat","year":"2014","unstructured":"Cazabat L, Dupuy M, Boulin A et al (2014) Silent, but not unseen: multimicrocystic aspect on T2-weighted MRI in silent corticotroph adenomas. Clin Endocrinol (Oxf) 81:566\u2013572. https:\/\/doi.org\/10.1111\/CEN.12443","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1428_CR31","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/CEN.14133","volume":"92","author":"L Kasuki","year":"2020","unstructured":"Kasuki L, Antunes X, Coelho MCA et al (2020) Accuracy of microcystic aspect on T2-weighted MRI for the diagnosis of silent corticotroph adenomas. Clin Endocrinol (Oxf) 92:145\u2013149. https:\/\/doi.org\/10.1111\/CEN.14133","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1428_CR32","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/S11102-018-0864-8","volume":"21","author":"A Ben-Shlomo","year":"2018","unstructured":"Ben-Shlomo A, Cooper O (2018) Silent corticotroph adenomas. Pituitary 21:183\u2013193. https:\/\/doi.org\/10.1007\/S11102-018-0864-8","journal-title":"Pituitary"},{"key":"1428_CR33","doi-asserted-by":"publisher","first-page":"e464","DOI":"10.1016\/J.WNEU.2018.04.070","volume":"115","author":"D Kim","year":"2018","unstructured":"Kim D, Ku CR, Park SH et al (2018) Clinical parameters to Distinguish Silent Corticotroph Adenomas from other Nonfunctioning Pituitary Adenomas. World Neurosurg 115:e464\u2013e471. https:\/\/doi.org\/10.1016\/J.WNEU.2018.04.070","journal-title":"World Neurosurg"},{"key":"1428_CR34","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1227\/00006123-199604000-00027","volume":"38","author":"K Thapar","year":"1996","unstructured":"Thapar K, Scheithauer BW, Kovacs K et al (1996) p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions. Neurosurgery 38:765\u2013771. https:\/\/doi.org\/10.1227\/00006123-199604000-00027","journal-title":"Neurosurgery"},{"key":"1428_CR35","doi-asserted-by":"publisher","unstructured":"Buckley N, Bates AS, Broome JC et al (1995) P53 protein accumulates in Cushings adenomas and invasive non-functional adenomas. J Clin Endocrinol Metab 80:4 p following 6\u2009\u2013\u20094 p following 6. https:\/\/doi.org\/10.1210\/JCEM.80.2.7852482","DOI":"10.1210\/JCEM.80.2.7852482"},{"key":"1428_CR36","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/J.1365-2265.2008.03404.X","volume":"70","author":"ST Kawashima","year":"2009","unstructured":"Kawashima ST, Usui T, Sano T et al (2009) P53 gene mutation in an atypical corticotroph adenoma with Cushing\u2019s disease. Clin Endocrinol (Oxf) 70:656\u2013657. https:\/\/doi.org\/10.1111\/J.1365-2265.2008.03404.X","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1428_CR37","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/S12022-013-9270-Y","volume":"24","author":"O Mete","year":"2013","unstructured":"Mete O, Hayhurst C, Alahmadi H et al (2013) The role of mediators of cell invasiveness, motility, and migration in the pathogenesis of silent corticotroph adenomas. Endocr Pathol 24:191\u2013198. https:\/\/doi.org\/10.1007\/S12022-013-9270-Y","journal-title":"Endocr Pathol"},{"key":"1428_CR38","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/J.ECL.2020.05.005","volume":"49","author":"S Barry","year":"2020","unstructured":"Barry S, Korbonits M (2020) Update on the Genetics of Pituitary tumors. Endocrinol Metab Clin North Am 49:433\u2013452. https:\/\/doi.org\/10.1016\/J.ECL.2020.05.005","journal-title":"Endocrinol Metab Clin North Am"},{"key":"1428_CR39","doi-asserted-by":"publisher","unstructured":"Uraki S, Ariyasu H, Doi A et al (2020) MSH6\/2 and PD-L1 expressions are Associated with Tumor Growth and Invasiveness in Silent Pituitary Adenoma subtypes. Int J Mol Sci 21. https:\/\/doi.org\/10.3390\/IJMS21082831","DOI":"10.3390\/IJMS21082831"},{"key":"1428_CR40","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1530\/EJE-21-1183","volume":"187","author":"D Zhang","year":"2022","unstructured":"Zhang D, Hugo W, Bergsneider M et al (2022) Single-cell RNA sequencing in silent corticotroph tumors confirms impaired POMC processing and provides new insights into their invasive behavior. Eur J Endocrinol 187:49\u201364. https:\/\/doi.org\/10.1530\/EJE-21-1183","journal-title":"Eur J Endocrinol"},{"key":"1428_CR41","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ccell.2019.11.002","volume":"37","author":"M Neou","year":"2020","unstructured":"Neou M, Villa C, Armignacco R et al (2020) Pangenomic classification of Pituitary neuroendocrine tumors. Cancer Cell 37:123\u2013134. e5","journal-title":"Cancer Cell"},{"key":"1428_CR42","doi-asserted-by":"publisher","first-page":"E273","DOI":"10.1210\/CLINEM\/DGAA708","volume":"106","author":"Z Wang","year":"2021","unstructured":"Wang Z, Guo X, Wang W et al (2021) UPLC-MS\/MS-based Lipidomic Profiles Revealed Aberrant Lipids Associated with Invasiveness of Silent Corticotroph Adenoma. J Clin Endocrinol Metab 106:E273\u2013E287. https:\/\/doi.org\/10.1210\/CLINEM\/DGAA708","journal-title":"J Clin Endocrinol Metab"},{"key":"1428_CR43","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/S11102-023-01345-0\/TABLES\/3","volume":"26","author":"A Giustina","year":"2023","unstructured":"Giustina A, Uygur MM, Frara S et al (2023) Pilot study to define criteria for Pituitary Tumors Centers of Excellence (PTCOE): results of an audit of leading international centers. Pituitary 26:583\u2013596. https:\/\/doi.org\/10.1007\/S11102-023-01345-0\/TABLES\/3","journal-title":"Pituitary"},{"key":"1428_CR44","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/NG.3166","volume":"47","author":"M Reincke","year":"2015","unstructured":"Reincke M, Sbiera S, Hayakawa A et al (2015) Mutations in the deubiquitinase gene USP8 cause Cushing\u2019s disease. Nat Genet 47:31\u201338. https:\/\/doi.org\/10.1038\/NG.3166","journal-title":"Nat Genet"},{"key":"1428_CR45","doi-asserted-by":"publisher","first-page":"E997","DOI":"10.1210\/JC.2015-1453","volume":"100","author":"LG Perez-Rivas","year":"2015","unstructured":"Perez-Rivas LG, Theodoropoulou M, Ferra\u00f9 F et al (2015) The gene of the ubiquitin-specific protease 8 is frequently mutated in Adenomas causing Cushing\u2019s Disease. J Clin Endocrinol Metab 100:E997\u2013E1004. https:\/\/doi.org\/10.1210\/JC.2015-1453","journal-title":"J Clin Endocrinol Metab"},{"key":"1428_CR46","doi-asserted-by":"publisher","unstructured":"P\u0119kul M, Szczepaniak M, Kober P et al (2024) Relevance of mutations in protein deubiquitinases genes and TP53 in corticotroph pituitary tumors. Front Endocrinol (Lausanne) 15. https:\/\/doi.org\/10.3389\/FENDO.2024.1302667","DOI":"10.3389\/FENDO.2024.1302667"},{"key":"1428_CR47","doi-asserted-by":"publisher","unstructured":"Yamamoto M, Nakao T, Ogawa W, Fukuoka H (2021) Aggressive Cushing\u2019s Disease: Molecular Pathology and its therapeutic Approach. Front Endocrinol (Lausanne) 12. https:\/\/doi.org\/10.3389\/FENDO.2021.650791","DOI":"10.3389\/FENDO.2021.650791"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-024-01428-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-024-01428-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-024-01428-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T04:56:02Z","timestamp":1730868962000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-024-01428-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,12]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["1428"],"URL":"https:\/\/doi.org\/10.1007\/s11102-024-01428-6","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,12]]},"assertion":[{"value":"3 July 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}